Healthcare and biotech
26 posts
UCB caught my attention today due to its impressive revenue performance and updated outlook for 2026. The company reported a Non-GAAP EPS of €6.84 and revenue of €4.27 billion, wh...
UnitedHealth Group UNH has been making waves in the stock market recently, and it’s caught my attention for a few reasons. The company not only surpassed earnings estimates but al...
HCA Healthcare has been on my radar lately, primarily due to its recent drop in stock price following an announcement that it was lowering its annual earnings outlook. This was at...
Biogen BIIB recently made headlines with its audacious $1 billion investment in a company that has chosen to remain in the shadows, not disclosing what it actually makes. This kin...
KKR has caught my attention today with its recent strategic moves, particularly the launch of a $1.3 billion renewable energy venture in South Korea. This development is part of a...
Johnson & Johnson JNJ has been making waves recently, catching my attention as a potential safe haven amidst the market's current volatility. With tech stocks facing a rough patch...
CVS Health has caught my attention today, mainly because it's been under the microscope following a recent healthcare report. As someone who enjoys digging into the nitty-gritty o...
GSK has been making headlines recently with its $10.6 billion acquisition of Nuvalent, a U.S.-based cancer drugmaker. This deal caught my attention because it represents a signifi...
UnitedHealth Group UNH has caught my attention this week due to its presence in notable healthcare headlines alongside big names like Pfizer and Eli Lilly. But while the news migh...
When I stumbled upon the news of Immunic naming Erik Lundgren as CEO, it caught my attention. The company is advancing its Phase 3 trials in multiple sclerosis MS, a disease that'...
LTC Properties caught my eye today, mainly because they recently had their Q1 earnings call. This kind of event often provides insights into a company's current performance and fu...
GSK caught my attention today due to a couple of recent developments that have stirred the pot for this pharmaceutical giant. The company's new drug, efimosfermin, has received re...
Eli Lilly LLY has been catching my eye lately, especially with its reputation in the weight-loss drug market. However, I'm not entirely sure if it's the right time to jump on boar...
HCA Healthcare recently caught my attention due to its Q1 2026 earnings call, which seems to be stirring quite a bit of discussion. With a trending score of 406.9 and several rece...
Johnson & Johnson JNJ has caught my attention today, mainly because of its recent mentions in dividend discussions. With a trending score of 78.9, JNJ seems to be on the radar for...
Organon OGN has recently caught my attention, and probably yours too, with its stock price surging 39% following rumors of a $12-billion merger. This kind of price movement is har...
UnitedHealth Group UNH caught my attention today, not just because it's among the stocks making the biggest moves, but also due to recent developments that could impact its future...
Humana HUM has been making waves as one of the biggest stock movers recently, catching my attention for its significant fluctuations. The stock's performance has been a mixed bag,...
Soleno Therapeutics SLNO has caught my attention due to its recent launch activities and the buzz around its stock performance. With a trending score of 89.9 and some recent menti...
LeMaitre Vascular LMAT recently caught my attention due to a notable insider sale. An insider sold 2,625 shares for $285,000, which naturally piqued my curiosity about the company...
I’ve been keeping an eye on CE lately, especially after Roche received CE approval for their Elecsys ApoE4 biomarker test. This approval could be a significant catalyst for the co...
Argenx SE caught my attention today due to its intriguing financial results and the mixed signals coming from the market. With a market cap of $61.8 billion and a decent trending...
ImmunityBio IBRX caught my attention today, mainly due to its eye-popping 700% revenue surge driven by the rapid adoption of its product, ANKTIVA. This kind of growth is hard to i...
Johnson & Johnson JNJ caught my eye today, not just because it's a household name, but because it's been getting a lot of buzz for its reliability and potential to anchor a retirem...
Global Partners LP GLP caught my attention today because of recent developments involving the FDA's crackdown on GLP-1 pills. Hims & Hers Health, a company that had been offering...
Eli Lilly LLY has been grabbing attention lately, not just for its massive market cap of nearly $949 billion, but also due to some pretty impressive growth projections. Analysts a...